Ovarian Function Recovery During Anastrozole in Breast Cancer Patients With Chemotherapy-Induced Ovarian Function Failure

Irene E. G. van Hellemond, Ingeborg J. H. Vriens, Petronella G. M. Peer, Astrid C. P. Swinkels, Carolien H. Smorenburg, Caroline M. Seynaeve, Maurice J. C. van der Sangen, Judith R. Kroep, Hiltje de Graaf, Aafke H. Honkoop, Frans L. G. Erdkamp, Franchette W. P. J. van den Berkmortel, Jos J. E. M. Kitzen, Maaike de Boer, Wilfred K. de Roos, Sabine C. Linn, Alexander L. T. Imholz, Vivianne C. G. Tjan-Heijnen*, Dutch Breast Canc Res Grp BOOG

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Article number074
Number of pages9
JournalJournal of the National Cancer Institute
Volume109
Issue number12
DOIs
Publication statusPublished - Dec 2017

Keywords

  • ADJUVANT ENDOCRINE THERAPY
  • AROMATASE INHIBITORS
  • POSTMENOPAUSAL WOMEN
  • INDUCED AMENORRHEA
  • AMERICAN-SOCIETY
  • LETROZOLE
  • EXEMESTANE
  • TRIAL
  • SUPPRESSION
  • TAMOXIFEN

Cite this